Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.62 USD | +1.58% | +7.65% | -4.76% |
May. 02 | Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating | MT |
May. 01 | Top Midday Gainers | MT |
Financials (USD)
Sales 2024 * | 123M | Sales 2025 * | 138M | Capitalization | 494M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -2M | EV / Sales 2024 * | 4.02 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.59 x |
P/E ratio 2024 * |
-44.5
x | P/E ratio 2025 * |
-223
x | Employees | 376 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.79% |
Latest transcript on Surmodics, Inc.
1 day | +1.58% | ||
1 week | +7.65% | ||
Current month | +34.76% | ||
1 month | +30.69% | ||
3 months | +10.64% | ||
6 months | -1.34% | ||
Current year | -4.76% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Maharaj
CEO | Chief Executive Officer | 61 | 10-12-26 |
Timothy Arens
DFI | Director of Finance/CFO | 57 | 07-01-31 |
Teri L. Sides
PRN | Corporate Officer/Principal | 55 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Kalich
BRD | Director/Board Member | 77 | 14-02-16 |
Susan Knight
CHM | Chairman | 70 | 08-01-28 |
José Bedoya
BRD | Director/Board Member | 68 | 01-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.21% | 25 M€ | -1.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 34.62 | +1.58% | 36,940 |
24-05-16 | 34.08 | +1.55% | 38,885 |
24-05-15 | 33.56 | +1.70% | 183,250 |
24-05-14 | 33 | +1.69% | 56,626 |
24-05-13 | 32.45 | +0.90% | 50,046 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.76% | 494M | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.04% | 42.73B | |
+25.54% | 32.52B | |
+20.86% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- SRDX Stock